Study | Reason for exclusion |
---|---|
Aertgeerts 1985 | The study included participants with different dermatoses on arms, hands, and legs. It was not clear for which participants the hands were involved and how the outcome was in the participants with hand eczema. This within‐participant study was not randomised and therefore was excluded |
Berndt 2001 | Participants did not have hand eczema. The study examined slightly irritated hands in nurses. The study may be included in the Skin Group Review titled "Interventions for preventing occupational irritant hand dermatitis" |
Chen 2015 | Hand and foot eczema combined; no separate data available |
Gergovska 2017 | Study focusses on prevention instead of treatment for active disease |
Grivcheva‐Panovska 2013 | Study on Staphylococcus aureus colonisation instead of hand eczema |
Güler Özden 2004 | Not clear whether participants were randomised to different treatment arms |
HogenEsch 1998 | Pilot study, in which it is unclear how many were allocated to each intervention. Not clear if the study was randomised |
Petering 2004 | Non‐randomised study with a within‐participant (left‐right) design. It could be argued whether randomisation is important in this left‐right study with bilateral hand eczema of similar severity. Observer of outcomes was blinded |
Rosén 1987 | Quasi‐randomised |
Zeichner 2018 | Single‐arm study without a comparator |
Zimmerman 1967 | It is unclear whether this within‐participant study was randomised Study on 54 participants with "bilateral, symmetrical areas of dermatitis" and stating only the preference for betamethasone 17‐valerate or fluocinolone acetonide ointment for 8 participants with hand eczema. No other outcomes for hand eczema specified. No information on frequency, dosage, and duration of treatment |